OZOBAX
- Product NDC
- 69528-302
- 11-digit product format
- 695280302
- Labeler code
- 69528
- Product ID
- 69528-302_4ce95252-8c9b-2246-e063-6294a90a8b25
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Baclofen
- Dosage form
- SOLUTION
- Route
- ORAL
- Labeler
- Rosemont Pharmaceuticals LLC
- Application
- NDA208193
- Marketing category
- NDA
- Marketing start
- 2023-10-12
- Substance
- BACLOFEN
- Active strength
- 10 mg/5mL
- Pharmacologic classes
- GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- OZOBAX
- Brand name suffix
- DS
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| BACLOFEN | 10 mg/5mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | H789N3FKE8 |
| Rxcui | 2667941, 2667943 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 69528-302-08 | OZOBAXDS | 237 mL in 1 BOTTLE | SOLUTION | 237 | | 2 |
| 69528-302-16 | OZOBAXDS | 473 mL in 1 BOTTLE | SOLUTION | 473 | | 2 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 69528-302 | OZOBAX DS (BACLOFEN) SOLUTION [METACEL PHARMACEUTICALS, LLC] | 1 | Current NDC, 2 package rows | 20231019_d8ddcec5-debe-42b4-a803-e65917cc6a54.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 69528-302-08 | 69528030208 | 237 mL in 1 BOTTLE (69528-302-08) | 237 ml | 2023-10-12 | No | No | Current |
| 69528-302-16 | 69528030216 | 473 mL in 1 BOTTLE (69528-302-16) | 473 ml | 2023-10-12 | No | No | Current |